DOI QR코드

DOI QR Code

Herpes zoster ophthalmicus after COVID-19 vaccine booster in healthy younger adult: a case report

  • Zamrud Wilda Nuril Awaly (Bhayangkara Hospital)
  • Received : 2022.10.24
  • Accepted : 2023.01.08
  • Published : 2023.01.31

Abstract

There were growing reports of herpes zoster reactivation after the coronavirus disease 2019 (COVID-19) vaccination, including a more severe form, herpes zoster ophthalmicus (HZO). A 35-year-old male presented HZO in his left V1 dermatome 10 days after his COVID-19 vaccine booster with Moderna (messenger RNA-1273). He had no history of chronic disease, immunocompromised, autoimmune, malignancy, or long-term immunosuppressive drug use. The rash improved without any further complications after being treated with oral valacyclovir for 7 days. This was a unique case of HZO after the COVID-19 vaccine in a booster setting in healthy younger adults. The association of herpes zoster after a COVID vaccine remained inconclusive and potentially coincidental, especially without the known risk factor. However, we would like to add a report to increase awareness among physicians and the general population, for early recognition and treatment with an antiviral.

Keywords

References

  1. Nugraha RR, Miranda AV, Ahmadi A, Lucero-Prisno DE 3rd. Accelerating Indonesian COVID-19 vaccination rollout: a critical task amid the second wave. Trop Med Health 2021;49:76.
  2. Mascellino MT, Di Timoteo F, De Angelis M, Oliva A. Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety. Infect Drug Resist 2021;14:3459-76.
  3. Katsikas Triantafyllidis K, Giannos P, Mian IT, Kyrtsonis G, Kechagias KS. Varicella zoster virus reactivation following COVID-19 vaccination: a systematic review of case reports. Vaccines (Basel) 2021;9:1013.
  4. Madavaraju K, Koganti R, Volety I, Yadavalli T, Shukla D. Herpes simplex virus cell entry mechanisms: an update. Front Cell Infect Microbiol 2021;10:617578.
  5. Alpalhao M, Filipe P. Herpes zoster following SARS-CoV-2 vaccination: a series of four cases. J Eur Acad Dermatol Venereol 2021;35:e750-2.
  6. Arora P, Sardana K, Mathachan SR, Malhotra P. Herpes zoster after inactivated COVID-19 vaccine: a cutaneous adverse effect of the vaccine. J Cosmet Dermatol 2021;20:3389-90.
  7. Psichogiou M, Samarkos M, Mikos N, Hatzakis A. Reactivation of varicella zoster virus after vaccination for SARSCoV-2. Vaccines (Basel) 2021;9:572.
  8. Maldonado MD, Romero-Aibar J. The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus. Brain Behav Immun Health 2021;18:100381.
  9. Lee C, Cotter D, Basa J, Greenberg HL. 20 Post-COVID-19 vaccine-related shingles cases seen at the Las Vegas Dermatology clinic and sent to us via social media. J Cosmet Dermatol 2021;20:1960-4.
  10. Channa L, Torre K, Rothe M. Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination. JAAD Case Rep 2021;15:60-1.
  11. Papasavvas I, de Courten C, Herbort CP Jr. Varicella-zoster virus reactivation causing herpes zoster ophthalmicus (HZO) after SARS-CoV-2 vaccination: report of three cases. J Ophthalmic Inflamm Infect 2021;11:28.
  12. Thimmanagari K, Veeraballi S, Roach D, Al Omour B, Slim J. Ipsilateral zoster ophthalmicus post COVID-19 vaccine in healthy young adults. Cureus 2021;13:e16725.
  13. Martinez-Reviejo R, Tejada S, Adebanjo GA, et al. Varicella-zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: new insights. Eur J Intern Med 2022;104:73-9.
  14. Desai HD, Sharma K, Shah A, et al. Can SARS-CoV-2 vaccine increase the risk of reactivation of varicella zoster?: a systematic review. J Cosmet Dermatol 2021;20:3350-61.
  15. Job AM, Sudhamani B, Mohan M, Mohanasundaram SN. Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant). Indian J Public Health 2022;66:83-5.